Webinar: eConsent - The Good, the Bad, and the Regulatory

How smart trials are leveraging eConsent to improve comprehension and reduce dropout

 

For clinical trial patients, the informed consent process has long been in need of optimization. High patient attrition rates indicate that we’re not doing enough to ensure patients truly understand the risks and burdens inherent in clinical trial participation. We can do better. As we rethink informed consent to improve it for all stakeholders - especially patients - electronic informed consent (eConsent) has a key role to play. Join Gabe Westerlund, Solutions Engineer at Medrio, as he explores the opportunities presented by the advent of eConsent, and how the consent process is evolving to deal with changes in technology, a focus on patient centricity, shifting guidance, and regulatory pressures.

Presented by
Gabriel Westerlund
Solutions Engineer, Medrio

Laurin Willetts
Customer Success Manager, Medrio

Laurin Willetts has over fifteen years of experience in clinical trials, program management, and research and development, and has worked in lab and business settings. She been instrumental in managing several clinical trials resulting with FDA clearance, particularly at diagnostics sponsor companies.  Her experience includes building clinical trial programs from the ground up, including processes and infrastructure, site feasibility/selection, contracts/budgets, database build, study start-up, patient enrollment, and metrics.

Speaker Name
Speaker Title

Sed ac purus sit amet nisl tincidunt tincidunt vel at dolor. In ullamcorper nisi risus, quis fringilla nibh mattis ac. Mauris interdum interdum eros, eget tempus lectus aliquet at. Suspendisse convallis suscipit odio, ut varius enim lacinia in. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Watch Now!